LOS ANGELES–(BUSINESS WIRE)—- $NAGE #AtHomeInjection–Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the launch of its clinician-directed telehealth platform under Niagen™ Plus, enabling eligible patients in the U.S. to access prescription-only, pharmaceutical-grade Niagen® (patented…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
